Notice of server maintenance. Membership dues payment will be offline for 24 hours. Check back on Thursday afternoon if you wish to pay your dues.

Trainee Track Webinar Wednesday, February 28, 2018

Trainee Track Webinar
Making CME Matter: Innovative Solutions to Maximize the Impact of Medical Education
Wednesday, February 28, 2018, 11am EST (Montreal time)

  To view the recording of the presentation click here (You must be logged into the website)


Alexander S. Niven
Dr. Alexander S. Niven graduated AOA from Tufts University School of Medicine, and completed his post-graduate training in Internal Medicine and Pulmonary / Critical Care medicine at Walter Reed Army Medical Center. He is retired from the Army Medical Department after 21 years of active duty service, during which he served as an Internal Medicine Program Director, Director of Medical Education and Research, and Designated Institutional Official at Madigan Army Medical Center in Tacoma, WA. Dr. Niven is currently a Senior Associate Consultant in the Division of Pulmonary and Critical Care Medicine, and is an Associate Professor of Medicine in the Mayo Clinic College of Medicine. He has extensive experience in outcomes based curriculum development and simulation based medical education, and his current efforts include examining the best use of educational strategies within the field of implementation science. He is a fellow in the American College of Chest Physicians (FCCP), and currently serves as the Chair of that organization's Education Committee.



Medhat Askar
Professor,Texas A&M College of Medicine & Director, Baylor Transplant Immunology


The goal of continuing medical education (CME) is to speed dissemination and adoption of best practices by physicians and their healthcare teams. Increasing focus on healthcare team performance and growing demands on their time and resources underlines the importance of efficient, effective CME opportunities. This webinar will discuss innovative CME solutions using current education design and active learning strategies, with practical examples using the collaborative experience of volunteer members and staff from the American College of Chest Physicians (CHEST).

Learning Objectives:

  1. Describe current outcomes evidence and future directions for CME based on the current healthcare environment and needs.
  2. Discuss practical applications of medical education theory and active learning strategies to increase efficient transfer of knowledge, skills, and attitudes through CME activities.
  3. Relate these applications to CME opportunities offered by medical societies, offering past and current CHEST CME efforts and innovations as examples.

Trainee Track Webinar Wednesday November 22, 2017

Trainee Track Webinar
Epitope Matching: What is it, and what is its relevance?
Wednesday, November 22, 2017, 11am EST (Montreal time)

  To view the recording of the presentation click here (You must be logged into the website)


Peter Nickerson, BSc (Med), MD, FRCPC, FCAHS
Distinguished Professor of Internal Medicine and Immunology
Vice-Dean of Research
Rady Faculty of Health Sciences
University of Manitoba
Medical Director of Transplant Manitoba and Medical Advisor
Organ Donation and Transplantation Division
Canadian Blood Services
Winnipeg, Manitoba, Canada

Peter Nickerson, BSc (Med), MD, FRCPC, FCAHS


Robert Liwski, MD, PhD, FRCPC
Medical Director, HLA Typing Laboratory
Staff Hematopathologist, Division of Hematopathology
Queen Elizabeth II Health Sciences Centre
Professor, Departments of Pathology and Microbiology & Immunology
Dalhousie University
Halifax, Nova Scotia, Canada

Robert Liwski, MD, PhD, FRCPC


Adequacy of immunosuppression is central to holding the alloimmune response in check. Clinicians and patients constantly seek to lower immunosuppressive therapy to minimize the risk for serious adverse events or avoid annoying side-effects leading to clinician-guided under immunosuppression and patient nonadherence. Unfortunately, at present there is no validated predictive biomarker to inform clinicians who can and cannot be safely minimized. The risk of minimization is de novo DSA resulting in antibody-mediated rejection, transplant glomerulopathy and premature graft failure. Moreover, once this process is underway, at present physicians have no effective therapy to turn it off. In the last few years it has been appreciated that computational approaches predicting potential antibody binding epitopes on the mismatched donor and the recipient HLA molecules can be used to predict alloimmune risk for de novo DSA, late acute rejections and graft failure. If this is further validated, then we may have for the first time a predictive biomarker able to aid clinicians safely personalize immunosuppressive therapy.

Peter Nickerson - Biography:

Dr. Peter Nickerson is a Distinguished Professor of Internal Medicine and Immunology and the Vice-Dean Research, Rady Faculty of Health Sciences at the University of Manitoba. He is the Medical Director of Transplant Manitoba and the Medical Advisor, Organ Donation and Transplantation Division, Canadian Blood Services (CBS).

Dr. Nickerson holds the Flynn Family Chair in Renal Transplantation at the University of Manitoba. Funded by the CIHR and NIH, his research program focuses on mechanisms underlying acute and chronic transplant rejection; developing non-invasive techniques for the diagnosis of renal allograft rejection; and health care system design to enhance access to transplant.

Robert Liwski - Biography:

Dr. Liwski obtained his PhD in Transplantation Immunology in 1999, his MD degree in 2003 and completed his fellowship training in Hematological Pathology in 2006, all at Dalhousie University. His research interests include transplantation immunology, ischemia reperfusion injury and optimization of diagnostic testing in transplantation. Dr. Liwski has developed several optimized HLA antibody testing methods including the Halifax/Halifaster flow crossmatch protocols and the Rapid Optimized Single Antigen Bead (ROB) assay. He was awarded the Canadian Association of Pathologists Junior Scientist Award for his research investigating the role of activated protein C in prevention of ischemia reperfusion injury and cancer metastasis.

Trainee Track Webinar Thursday, May 11, 2017

Trainee Track Webinar
Balancing Career and Personal Life: Establishing Priorities and Achieving Job Satisfaction
Thursday, May 11, 2017, 11am EDT (Montreal time)

  To view the recording of the presentation click here (You must be logged into the website)


Martha Pavlakis, MD
Medical Director of Kidney and Pancreas Transplantation
Associate Professor of Medicine
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, MA, United States

Martha Pavlakis, MD


Yolanda Becker, MD, FACS
Vice President, United Network for Organ Sharing
Professor of Surgery
Director of Kidney and Pancreas Transplantation
University of Chicago
Chicago, IL, United States

Yolanda Becker, MD, FACS


This topic is not just for women and not just for people with kids. The challenge of establishing priorities and achieving job satisfaction applies to everyone in this field. Burnout is more common among physicians than among other US workers. We will start the webinar by defining family as more than just the narrow nuclear family. In developing an understanding of the causes of burnout, we will maintain a healthy respect for a variety of life choices, cultural and socioeconomic differences. The importance of resilience will be discussed and we will finish with a discussion of resources in the work/life integration toolbox.

Martha Pavlakis - Biography:

Dr. Pavlakis graduated from SUNY at Buffalo School of Medicine and completed internal medicine training at Tufts New England Medical Center.  She then completed both a renal fellowship and clinical investigation fellowship at Beth Israel Hospital, researching gene expression in kidney transplant rejection. In 1999, after 3 years at Stanford Medical Center where she was a transplant nephrologist and had a research lab, she returned to the newly merged Beth Israel Deaconess Medical Center and became the medical director of kidney and pancreas transplantation. She is an associate professor of medicine at Harvard Medical School and has continued to publish scholarly articles in the field of kidney and pancreas transplantation and kidney donation. She is currently the region 1 representative to the UNOS Kidney Committee and serves on the American Society of Transplantation Education Committee.  She has three sons ranging in age from 16 to 23, has a daily meditation practice and has studied Iyengar yoga for the past 11 years.

Yolanda Becker - Biography:

Dr. Becker is vice president of the OPTN/UNOS board of directors and of the UNOS corporate affairs committee, additionally serving as a member of the nominating committee and the board governance subcommittee. She has chaired the policy oversight committee. She also has served on the membership and professional standards committee (MPSC) and its performance analysis and improvement subcommittee. She additionally has been a member of MPSC’s performance and certification, and certification maintenance workgroups, co-chairing the latter.

Dr. Becker has served as an elected member of the American Society of Transplantation (AST) board of directors, co-chairing its winter symposium, chairing its education committee and additionally serving on the minority affairs committee. She has served on the American Society of Transplant Surgeons (ASTS) scientific studies committee and on the AST/ASTS American Transplant Congress program planning committee. She also has served on the board of directors of the National Kidney Registry.

She earned her medical degree at the Johns Hopkins School of Medicine in Baltimore. Dr. Becker has received additional leadership training, completing the Executive Leaders in Academic Medicine program at Drexel University College of Medicine in Philadelphia.

Trainee Track Webinar Thursday, April 13, 2017

Trainee Track Webinar
Getting Your Research Published in High Impact Journals
Thursday, April 13, 2017, 11am EST (Montreal time)

  To view the recording of the presentation click here (You must be logged into the website)


Allan D. Kirk, MD, PhD
Professor of Surgery, Professor in the Department of Immunology, Professor in Pediatrics
Chair, Department of Surgery
Duke University School of Medicine
Durham, NC, United States

Allan D. Kirk, MD, PhD


Robert L. Fairchild, PhD
Professor of Molecular Medicine
Cleveland Clinic Lerner College of Medicine
Cleveland, Ohio
Professor of Pathology
Case Western Reserve University School of Medicine
Cleveland, Ohio, United States

Robert L. Fairchild, PhD


This Webinar will provide an overview of medical publishing, particularly as it relates to transplantation. It will provide detail regarding the peer review process, introduce strategies for successfully navigating peer review and help demystify the process of journal review and publication.

Allan D. Kirk - Biography:

Allan D. Kirk is a native of Virginia Beach. He graduated from ODU in 1983, designated the Most Outstanding Senior in Biology, with a BS in Biology, summa cum laude. Thereafter, he received an MD and a PhD in Immunology from Duke University, where he also completed his surgery residency. He completed an organ transplant fellowship at the University of Wisconsin. Dr. Kirk served in the US Navy as a transplant surgeon and Chief of Transplant Research for the Armed Services Transplant Service in Washington, DC. During this time, he helped develop a new approach to preventing organ transplant rejection, known as costimulation blockade, and transitioned to the National Institutes of Health to develop this field further as Chief of their Transplantation Branch. In 2007, he moved to Emory University, as Vice Chair for Surgical Research, and in 2014, was appointed Chairman of the Department of Surgery at Duke University. He holds Professorships in Surgery, Pediatrics and Immunology and serves as Surgeon-in-Chief for the Duke University Health System. He has published >300 scientific manuscripts, and continues NIH- and FDA-sponsored investigations in organ transplantation, and DoD-sponsored work in limb replacement following combat amputation and immune management of catastrophic injury.  

Robert L. Fairchild - Biography:

Robert L. Fairchild received a doctorate in immunology at the University of Missouri-Columbia and completed a postdoctoral fellowship at the University of Colorado Health Sciences Center and the National Jewish Hospital for Allergy and Immunology in Denver. He is currently a Professor of Molecular Medicine in the Cleveland Clinic Lerner College of Medicine and Professor in the Department of Pathology at Case Western Reserve University School of Medicine in Cleveland, Ohio.

Dr. Fairchild has served terms as a member on 3 NIH study sections and is a former Chair of the Tumors, Transplantation, and Tolerance (TTT) study section. He is currently a Deputy Editor for both the American Journal of Transplantation and for the Journal of Immunology.

Dr. Fairchild is principal investigator on NIH-funded studies focused on the impact of endogenous CD8 memory T cell activity on allograft outcome and on mechanisms underlying antibody mediated rejection of renal allografts using mouse models as well as clinical samples. Dr. Fairchild is a member of the Clinical Trials for Organ Transplantation Consortium and Director of the Molecular Core for CTOT-19.

Trainee Track Webinar Thursday, March 9, 2017

Trainee Track Webinar
How to Write a Successful Clinical Science Grant
Thursday, March 9, 2017, 11am (Montreal time)

  To view the recording of the presentation click here (You must be logged into the website)


Peter Reese
Transplant Nephrologist and Epidemiologist
Associate Professor of Medicine
University of Pennsylvania Perelman School of Medicine
Philadelphia, PA, USA

Peter Reese Headshot Copy


Matthew Levine
Assistant Professor
Division of Transplant Surgery
Perelman School of Medicine
University of Pennsylvania
Surgical Director Renal Transplantation
Children’s Hospital of Philadelphia
Philadelphia, PA, USA

Matthew Levine Headshot


This Webinar will focus on the entire process of writing a clinical science grant, starting with a conceptual idea.

Peter Reese - Biography:

Peter Reese, MD, MSCE is a transplant nephrologist and epidemiologist. He is Associate Professor of Medicine (effective July 1 2017) at the University of Pennsylvania Perelman School of Medicine. His research focuses on: a) developing effective strategies to increase access to kidney transplantation, b) improving the process of selecting and caring for living kidney donors, c) determining outcomes of health policies on vulnerable populations with renal disease, including the elderly, and d) testing strategies to improve important health behaviors such as medication adherence. He chairs the Ethics Committee for the United Network for Organ Sharing (UNOS), which oversees organ allocation and transplant regulation in the US, and is an Associate Editor for the American Journal of Kidney Diseases. He is Co-Principal Investigator for the THINKER study, a pilot trial of kidney transplantation of hepatitis C positive kidneys into hepatitis C negative recipients ( NCT02743897). His research funding has included grants from the NIH, the American Society of Transplantation, the American Society of Nephrology, and the Greenwall Foundation.

Matthew Levine - Biography:

Matthew Levine was raised in Houston, Texas. He attended college at Brown University and then the Medical Scientist Training Program for a combined MD and PhD at Yale University. While there, he completed his PhD dissertation in immunobiology in the laboratory of Charles Janeway Jr., with work focusing on the discovery of positive selection events in the peripheral development of B cells. He then went on to complete general surgery residency at the Massachusetts General Hospital and a fellowship in abdominal organ transplantation at the University of California, San Francisco. He joined the faculty at the University of Pennsylvania in March, 2009 in the division of transplant surgery performing renal, liver and pancreas transplants in adults and children. He is the surgical director of the CHOP renal transplant program. He is a member of the ASTS, AST, AASLD, and TTS, and serves as chair of the CME committee of the ASTS. He serves on the basic science committee of the Society of University Surgeons and is a Fellow of the American College of Surgeons. He serves on the editorial boards of the American Journal of Transplantation and Liver Transplantation.

His scientific work focuses on two broad areas. The first is the role that histone/protein acetylation and de-acetylation plays in the tolerance of end organ ischemic injury – predominantly kidney and liver. This work has been facilitated several grants from NIH/NIDDK with the work performed in collaboration with the laboratory of Wayne Hancock at the Children’s Hospital of Philadelphia. He has an additional focus on the impact of hormone manipulation on ischemic injury. The second broad aspect of scientific inquiry has focused on vascularized composite tissue allotransplantation models in mice with a focus on tolerance induction. This work has involved multiple collaborators and is funded by multiple grants from the Department of Defense. Overall, his focus in on scientific inquiry with significant translatable potential in human transplantation.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi